OTC

GSK’s Consumer Health Flotation Flags

The Jul.18 launch of GSK’s consumer healthcare spinoff Haleon on the London Stock Exchange – said to be the largest London listing in more than a decade – seems to have gone off more like a whimper than a bang.

HRA Pharma Seeks FDA Approval for OTC Contraceptive

In the wake of the US Supreme Court’s recent overturn of Roe v. Wade, a 50-year-old decision by an earlier team of justices that guarantees women the right terminate a pregnancy, attention has turned to the so-called morning-after pill mifepristone – which remains legal for now – and easier access to birth control.

Takeda Sells OTC Drugs to Denmark’s Orifarm

Stada Boosts OTC Business with GSK Brands

Takeda Sells OTC Drugs to Acino

GSK-Pfizer Complete Consumer Health JV

Pfizer Mulls Sale of Consumer Health Unit

Iran: Rediscovering a Sleeping Giant

Alan Main to Head Sanofi OTC Business

Digitalization is changing supply chains in the healthcare industry

Perrigo Buying GSK, Novartis Consumer Brands

Pharma Production: Preparing for Serialization

Preparing for Tomorrow’s Pharmaceutical Challenges

Preparing for Tomorrow’s Pharmaceutical Challenges

Realignment of the Pharmaceutical Supply Chain in Japan

Drugmakers Eye Africa's Middle Classes as Next Growth Market

GSK Spends $900 Million to Lift Stake in India Consumer Arm

Merck KGaA to Resist Lure of Potential Proceeds from OTC Sale